豬瘟與豬藍(lán)耳病疫苗不同免疫程序?qū)γ庖咝Ч绊懙难芯?/H1>
發(fā)布時(shí)間：2018-01-08 08:06
本文關(guān)鍵詞：豬瘟與豬藍(lán)耳病疫苗不同免疫程序?qū)γ庖咝Ч绊懙难芯?/strong> 出處：《沈陽(yáng)農(nóng)業(yè)大學(xué)》2016年碩士論文 論文類型：學(xué)位論文
更多相關(guān)文章： 豬瘟 豬藍(lán)耳病 血液指標(biāo) 體液免疫 細(xì)胞免疫
【摘要】：古典型豬瘟(CSF)是一種非常嚴(yán)重的豬病毒性傳染病,尤其會(huì)對(duì)人口較為稠密的以養(yǎng)豬為主的國(guó)家造成重大的經(jīng)濟(jì)損失。豬藍(lán)耳病(PRRS)是迄今為止全世界各地區(qū)范圍內(nèi)在經(jīng)濟(jì)方面上造成最大負(fù)面影響的豬傳染病之一,據(jù)美國(guó)相關(guān)部門(mén)統(tǒng)計(jì),豬藍(lán)耳病每年對(duì)其本土養(yǎng)豬業(yè)保守估計(jì)造成超過(guò)約60億美元的經(jīng)濟(jì)財(cái)產(chǎn)損失。當(dāng)機(jī)體感染這兩種疾病以后,最終都會(huì)由于免疫功能徹底喪失、繼發(fā)其他疫病混合感染而死。豬瘟和豬藍(lán)耳病由于其各自特殊的致病機(jī)理而同屬于免疫抑制類疾病。免疫抑制疾病的發(fā)生是造成各大養(yǎng)豬場(chǎng)免疫防控失敗最不容忽視的因素之一,因此要想做好各類豬病的有效防控,控制好免疫抑制疾病的發(fā)生才是當(dāng)務(wù)之急。而當(dāng)前對(duì)于豬瘟和豬藍(lán)耳病這兩種免疫抑制疾病尚未形成統(tǒng)一、良好的免疫程序。因此針對(duì)二者摸索出一套合理、有效的免疫程序刻不容緩。本試驗(yàn)選取42頭健康未免疫的斷奶仔豬,將其中36頭隨機(jī)分為3組(A、B、C),每組設(shè)2個(gè)重復(fù),另外6頭作為空白對(duì)照。A組先免疫豬瘟間隔7天后免疫豬藍(lán)耳病,B組反之,C組采取同時(shí)分點(diǎn)免疫。分別于免疫前以及免疫后的第10、20、30、40、50、60、70天進(jìn)行前腔靜脈無(wú)菌采血,分別從血液指標(biāo)、料重比、體液免疫中特異性抗體的分泌水平、細(xì)胞免疫中T淋巴細(xì)胞的增殖能力以及IFN-γ的分泌水平這五個(gè)方面進(jìn)行比較分析,結(jié)果如下：①血液指標(biāo)結(jié)果顯示A組和C組平均白細(xì)胞數(shù)和淋巴細(xì)胞比例分別極顯著高于B組(p0.01)和對(duì)照組(p0.01),而其他指標(biāo)各組間均無(wú)顯著差異(p0.05)。②料重比結(jié)果A組最低,C組其次,B組最高。③特異性抗體的ELISA試劑盒檢測(cè)結(jié)果顯示A組豬瘟抗體平均阻斷率在免疫后第70天左右達(dá)到峰值并極顯著高于B組(p0.01)、C組(p0.01)和對(duì)照組(p0.01),實(shí)驗(yàn)組中B組最低(p0.01)；三個(gè)實(shí)驗(yàn)組豬藍(lán)耳病抗體平均S/P值均呈上升趨勢(shì),在免疫后第40天左右達(dá)到峰值,之后走勢(shì)趨于平穩(wěn),實(shí)驗(yàn)組免疫前后差異均極顯著(p0.01),但組間差異不顯著(p0.05),對(duì)照組無(wú)趨勢(shì)變化。④T淋巴細(xì)胞增值能力結(jié)果顯示A組平均刺激指數(shù)在免疫后第40天左右達(dá)到峰值并極顯著高于B組(p0.01)、C組(p0.01)和對(duì)照組(p0.01),實(shí)驗(yàn)組中B組最低(p0.01)。⑤IFN-γ分泌水平結(jié)果顯示A組平均IFN-γ濃度在免疫后第30天左右達(dá)到峰值并極顯著高于B組(p0.01)和對(duì)照組(p0.01),與C組差異不顯著(p0.05)綜上所述,不論是從血液指標(biāo),還是從料重比、體液免疫水平以及細(xì)胞免疫水平上來(lái)看,均可以得出一致結(jié)論,即先免疫豬瘟,間隔7天后再免疫豬藍(lán)耳病的免疫效果較好,此結(jié)論為將來(lái)制定豬瘟、豬藍(lán)耳病合理有效的免疫程序提供了一定的理論依據(jù)。
[Abstract]:Classical swine fever (CSF) is a very serious swine viral disease. In particular, significant economic losses will be caused to more densely populated countries where pig breeding is the main source of disease. Pig Blue ear Disease (PRRSs). So far, it is one of the most economically negative swine infectious diseases in all regions of the world. According to relevant departments in the United States, blue ear disease causes an estimated economic loss of more than $6 billion a year to the local pig industry, when the body becomes infected with the two diseases. Will eventually be completely lost to immune function. Swine fever and pig blue ear disease belong to immunosuppressive disease because of their special pathogenic mechanism. The occurrence of immunosuppressive disease is the most important cause of the failure of immune prevention and control in pig farms. One of the factors of neglect. Therefore, in order to effectively prevent and control all kinds of swine diseases, it is urgent to control the occurrence of immunosuppressive diseases. At present, the two immunosuppressive diseases, swine fever and pig blue ear disease, are not yet unified. Therefore, it is urgent to find out a set of reasonable and effective immunization procedures for the two groups. In this study, 42 healthy unimmunized weaned piglets were selected and 36 of them were randomly divided into 3 groups. Each group was divided into 2 replicates and the other 6 were used as blank control. Group A was immunized with swine fever at intervals of 7 days and then immunized with swine blue ear disease (group B). Group C was immunized at the same time, and the blood samples were collected from the anterior vena cava at day 102030, 4050 and 6070, respectively, according to the blood index and the ratio of feed to weight. The secretion level of specific antibody in humoral immunity, the proliferative ability of T lymphocytes in cellular immunity and the secretion level of IFN- 緯 were compared and analyzed. Results the average leukocyte count and lymphocyte percentage in group A and C were significantly higher than those in group B (p0.01) and control group (p0.01). However, there was no significant difference in other indexes among the groups. The results showed that the ratio of feed to weight of group A was the lowest and that of group C was the second. The results of ELISA kit of the highest specific antibody in group B showed that the average blocking rate of swine fever antibody in group A reached a peak value about 70 days after immunization and was significantly higher than that in group B (p0.01). Group C (P 0.01) and control group (P 0.01), group B was the lowest (P 0.01); The average S- P value of the three experimental groups showed an increasing trend, reached the peak at the 40th day after immunization, and then tended to be stable. The differences between the experimental groups before and after immunization were very significant (p0.01). But there was no significant difference between groups (p0.05). The results showed that the average stimulation index of group A reached its peak value about 40 days after immunization and was significantly higher than that of group B (p0.01). Group C (p0.01) and control group (p0.01). The results showed that the average IFN- 緯 concentration of group A reached its peak on the 30th day after immunization and was significantly higher than that of group B (p0.01). And control group (p0.01). Compared with group C, there was no significant difference (p0.05). In conclusion, the same conclusion can be drawn from the blood index, the ratio of feed to weight, the level of humoral immunity and the level of cellular immunity. The immune effect of swine fever was better than that of swine blue ear disease after 7 days' interval. This conclusion provides a theoretical basis for the formulation of reasonable and effective immunization procedures for swine fever and swine blue ear disease in the future.
【學(xué)位授予單位】：沈陽(yáng)農(nóng)業(yè)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：S858.28
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 田生花;何成偉;;藍(lán)耳病疫苗副反應(yīng)調(diào)查與改進(jìn)措施[J];養(yǎng)殖技術(shù)顧問(wèn);2008年03期
2 ;我國(guó)自主研發(fā)豬藍(lán)耳病疫苗告別進(jìn)口[J];吉林畜牧獸醫(yī);2011年03期
3 ;藍(lán)耳病疫苗使用時(shí)的注意事項(xiàng)[J];北方牧業(yè);2012年23期
4 ;豬藍(lán)耳病疫苗研制成功[J];臺(tái)灣農(nóng)業(yè)情況;1995年01期
5 ;天津研制成功豬藍(lán)耳病疫苗[J];北方牧業(yè);2004年19期
6 ;打藍(lán)耳病疫苗時(shí)的注意事項(xiàng)[J];北方牧業(yè);2006年24期
7 林太明;;警惕豬藍(lán)耳病疫苗使用不當(dāng)?shù)奈：J];養(yǎng)豬;2007年04期
8 花象柏;;豬藍(lán)耳病疫苗預(yù)防探討[J];獸藥與飼料添加劑;2008年03期
9 梁皓儀;;不同藍(lán)耳病疫苗的免疫效果—抗體效價(jià)分析[J];養(yǎng)豬;2008年04期
10 吳華偉;金麗霞;陳征;鄭明;;藍(lán)耳病疫苗的正確使用[J];中國(guó)獸藥雜志;2009年10期
相關(guān)會(huì)議論文 前4條
1 ;豬藍(lán)耳病疫苗的研究[A];新型疫苗研發(fā)及基因工程疫苗應(yīng)用研討會(huì)論文集[C];2010年
2 張長(zhǎng)龍;嚴(yán)寶英;賈文孝;劉學(xué)通;;豬瘟、豬口蹄疫、高致病性豬藍(lán)耳病疫苗有效免疫擴(kuò)大試驗(yàn)初探[A];中國(guó)畜牧獸醫(yī)學(xué)會(huì)家畜傳染病學(xué)分會(huì)第七屆全國(guó)會(huì)員代表大會(huì)暨第十三次學(xué)術(shù)研討會(huì)論文集（上冊(cè)）[C];2009年
3 陳建林;楊肖;王澤洲;章歡;程馳;李棟;王紅寧;李江凌;高榮;;豬白細(xì)胞介素4、6融合基因和CpG基序?qū)ωi藍(lán)耳病疫苗免疫的強(qiáng)化效應(yīng)[A];中國(guó)畜牧獸醫(yī)學(xué)會(huì)家畜傳染病學(xué)分會(huì)第七屆全國(guó)會(huì)員代表大會(huì)暨第十三次學(xué)術(shù)研討會(huì)論文集（上冊(cè)）[C];2009年
4 宋羚羚;杜春玲;余志;廖曉東;李巒峰;惠覓宙;;激流式生物反應(yīng)器培養(yǎng)Marc-145細(xì)胞生產(chǎn)豬藍(lán)耳病疫苗工藝研究[A];中國(guó)畜牧獸醫(yī)學(xué)會(huì)動(dòng)物傳染病學(xué)分會(huì)第四次豬病防控學(xué)術(shù)研討會(huì)論文集[C];2010年
相關(guān)重要報(bào)紙文章 前10條
1 肖柳;豬藍(lán)耳病疫苗“錢(qián)”景尚不明朗[N];證券時(shí)報(bào);2007年
2 胡軍華;豬藍(lán)耳病疫苗助力 中牧實(shí)業(yè)利潤(rùn)增近九成[N];第一財(cái)經(jīng)日?qǐng)?bào);2008年
3 朱兵;豬藍(lán)耳病疫苗[N];江蘇農(nóng)業(yè)科技報(bào);2003年
4 董少東;158萬(wàn)頭生豬免費(fèi)打藍(lán)耳病疫苗[N];北京日?qǐng)?bào);2007年
5 郭艾琳;12藥企緊急投產(chǎn)豬藍(lán)耳病疫苗 市場(chǎng)前景難定[N];第一財(cái)經(jīng)日?qǐng)?bào);2007年
6 吳桂亮;健康豬才能接種藍(lán)耳病疫苗[N];江蘇農(nóng)業(yè)科技報(bào);2007年
7 袁小可;首批豬藍(lán)耳病疫苗下線揭幕8億新市場(chǎng)[N];上海證券報(bào);2007年
8 郭立;全國(guó)首批豬藍(lán)耳病疫苗發(fā)放[N];西部時(shí)報(bào);2007年
9 ;藍(lán)耳病疫苗全國(guó)統(tǒng)一調(diào)撥停止[N];中國(guó)畜牧獸醫(yī)報(bào);2007年
10 趙海;天津研制出豬藍(lán)耳病疫苗[N];農(nóng)資導(dǎo)報(bào);2004年
相關(guān)碩士學(xué)位論文 前4條
1 郭士琪;豬瘟與豬藍(lán)耳病疫苗不同免疫程序?qū)γ庖咝Ч绊懙难芯縖D];沈陽(yáng)農(nóng)業(yè)大學(xué);2016年
2 王國(guó)強(qiáng);豬藍(lán)耳病疫苗免疫應(yīng)激及其免疫增強(qiáng)調(diào)節(jié)劑的研究[D];湖南農(nóng)業(yè)大學(xué);2009年
3 楊竹鳴;pVAX1-IFN-α作為豬藍(lán)耳病疫苗免疫佐劑的評(píng)價(jià)[D];南京農(nóng)業(yè)大學(xué);2012年
4 竇鵬勛;豬瘟、口蹄疫與藍(lán)耳病疫苗單獨(dú)和聯(lián)合免疫后豬體抗體水平的變化[D];西北農(nóng)林科技大學(xué);2009年
，
本文編號(hào)：1396276
本文鏈接：http://www.sikaile.net/yixuelunwen/dongwuyixue/1396276.html
本文關(guān)鍵詞：豬瘟與豬藍(lán)耳病疫苗不同免疫程序?qū)γ庖咝Ч绊懙难芯?/strong> 出處：《沈陽(yáng)農(nóng)業(yè)大學(xué)》2016年碩士論文 論文類型：學(xué)位論文
更多相關(guān)文章： 豬瘟 豬藍(lán)耳病 血液指標(biāo) 體液免疫 細(xì)胞免疫
【摘要】：古典型豬瘟(CSF)是一種非常嚴(yán)重的豬病毒性傳染病,尤其會(huì)對(duì)人口較為稠密的以養(yǎng)豬為主的國(guó)家造成重大的經(jīng)濟(jì)損失。豬藍(lán)耳病(PRRS)是迄今為止全世界各地區(qū)范圍內(nèi)在經(jīng)濟(jì)方面上造成最大負(fù)面影響的豬傳染病之一,據(jù)美國(guó)相關(guān)部門(mén)統(tǒng)計(jì),豬藍(lán)耳病每年對(duì)其本土養(yǎng)豬業(yè)保守估計(jì)造成超過(guò)約60億美元的經(jīng)濟(jì)財(cái)產(chǎn)損失。當(dāng)機(jī)體感染這兩種疾病以后,最終都會(huì)由于免疫功能徹底喪失、繼發(fā)其他疫病混合感染而死。豬瘟和豬藍(lán)耳病由于其各自特殊的致病機(jī)理而同屬于免疫抑制類疾病。免疫抑制疾病的發(fā)生是造成各大養(yǎng)豬場(chǎng)免疫防控失敗最不容忽視的因素之一,因此要想做好各類豬病的有效防控,控制好免疫抑制疾病的發(fā)生才是當(dāng)務(wù)之急。而當(dāng)前對(duì)于豬瘟和豬藍(lán)耳病這兩種免疫抑制疾病尚未形成統(tǒng)一、良好的免疫程序。因此針對(duì)二者摸索出一套合理、有效的免疫程序刻不容緩。本試驗(yàn)選取42頭健康未免疫的斷奶仔豬,將其中36頭隨機(jī)分為3組(A、B、C),每組設(shè)2個(gè)重復(fù),另外6頭作為空白對(duì)照。A組先免疫豬瘟間隔7天后免疫豬藍(lán)耳病,B組反之,C組采取同時(shí)分點(diǎn)免疫。分別于免疫前以及免疫后的第10、20、30、40、50、60、70天進(jìn)行前腔靜脈無(wú)菌采血,分別從血液指標(biāo)、料重比、體液免疫中特異性抗體的分泌水平、細(xì)胞免疫中T淋巴細(xì)胞的增殖能力以及IFN-γ的分泌水平這五個(gè)方面進(jìn)行比較分析,結(jié)果如下：①血液指標(biāo)結(jié)果顯示A組和C組平均白細(xì)胞數(shù)和淋巴細(xì)胞比例分別極顯著高于B組(p0.01)和對(duì)照組(p0.01),而其他指標(biāo)各組間均無(wú)顯著差異(p0.05)。②料重比結(jié)果A組最低,C組其次,B組最高。③特異性抗體的ELISA試劑盒檢測(cè)結(jié)果顯示A組豬瘟抗體平均阻斷率在免疫后第70天左右達(dá)到峰值并極顯著高于B組(p0.01)、C組(p0.01)和對(duì)照組(p0.01),實(shí)驗(yàn)組中B組最低(p0.01)；三個(gè)實(shí)驗(yàn)組豬藍(lán)耳病抗體平均S/P值均呈上升趨勢(shì),在免疫后第40天左右達(dá)到峰值,之后走勢(shì)趨于平穩(wěn),實(shí)驗(yàn)組免疫前后差異均極顯著(p0.01),但組間差異不顯著(p0.05),對(duì)照組無(wú)趨勢(shì)變化。④T淋巴細(xì)胞增值能力結(jié)果顯示A組平均刺激指數(shù)在免疫后第40天左右達(dá)到峰值并極顯著高于B組(p0.01)、C組(p0.01)和對(duì)照組(p0.01),實(shí)驗(yàn)組中B組最低(p0.01)。⑤IFN-γ分泌水平結(jié)果顯示A組平均IFN-γ濃度在免疫后第30天左右達(dá)到峰值并極顯著高于B組(p0.01)和對(duì)照組(p0.01),與C組差異不顯著(p0.05)綜上所述,不論是從血液指標(biāo),還是從料重比、體液免疫水平以及細(xì)胞免疫水平上來(lái)看,均可以得出一致結(jié)論,即先免疫豬瘟,間隔7天后再免疫豬藍(lán)耳病的免疫效果較好,此結(jié)論為將來(lái)制定豬瘟、豬藍(lán)耳病合理有效的免疫程序提供了一定的理論依據(jù)。
[Abstract]:Classical swine fever (CSF) is a very serious swine viral disease. In particular, significant economic losses will be caused to more densely populated countries where pig breeding is the main source of disease. Pig Blue ear Disease (PRRSs). So far, it is one of the most economically negative swine infectious diseases in all regions of the world. According to relevant departments in the United States, blue ear disease causes an estimated economic loss of more than $6 billion a year to the local pig industry, when the body becomes infected with the two diseases. Will eventually be completely lost to immune function. Swine fever and pig blue ear disease belong to immunosuppressive disease because of their special pathogenic mechanism. The occurrence of immunosuppressive disease is the most important cause of the failure of immune prevention and control in pig farms. One of the factors of neglect. Therefore, in order to effectively prevent and control all kinds of swine diseases, it is urgent to control the occurrence of immunosuppressive diseases. At present, the two immunosuppressive diseases, swine fever and pig blue ear disease, are not yet unified. Therefore, it is urgent to find out a set of reasonable and effective immunization procedures for the two groups. In this study, 42 healthy unimmunized weaned piglets were selected and 36 of them were randomly divided into 3 groups. Each group was divided into 2 replicates and the other 6 were used as blank control. Group A was immunized with swine fever at intervals of 7 days and then immunized with swine blue ear disease (group B). Group C was immunized at the same time, and the blood samples were collected from the anterior vena cava at day 102030, 4050 and 6070, respectively, according to the blood index and the ratio of feed to weight. The secretion level of specific antibody in humoral immunity, the proliferative ability of T lymphocytes in cellular immunity and the secretion level of IFN- 緯 were compared and analyzed. Results the average leukocyte count and lymphocyte percentage in group A and C were significantly higher than those in group B (p0.01) and control group (p0.01). However, there was no significant difference in other indexes among the groups. The results showed that the ratio of feed to weight of group A was the lowest and that of group C was the second. The results of ELISA kit of the highest specific antibody in group B showed that the average blocking rate of swine fever antibody in group A reached a peak value about 70 days after immunization and was significantly higher than that in group B (p0.01). Group C (P 0.01) and control group (P 0.01), group B was the lowest (P 0.01); The average S- P value of the three experimental groups showed an increasing trend, reached the peak at the 40th day after immunization, and then tended to be stable. The differences between the experimental groups before and after immunization were very significant (p0.01). But there was no significant difference between groups (p0.05). The results showed that the average stimulation index of group A reached its peak value about 40 days after immunization and was significantly higher than that of group B (p0.01). Group C (p0.01) and control group (p0.01). The results showed that the average IFN- 緯 concentration of group A reached its peak on the 30th day after immunization and was significantly higher than that of group B (p0.01). And control group (p0.01). Compared with group C, there was no significant difference (p0.05). In conclusion, the same conclusion can be drawn from the blood index, the ratio of feed to weight, the level of humoral immunity and the level of cellular immunity. The immune effect of swine fever was better than that of swine blue ear disease after 7 days' interval. This conclusion provides a theoretical basis for the formulation of reasonable and effective immunization procedures for swine fever and swine blue ear disease in the future.
【學(xué)位授予單位】：沈陽(yáng)農(nóng)業(yè)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：S858.28
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 田生花;何成偉;;藍(lán)耳病疫苗副反應(yīng)調(diào)查與改進(jìn)措施[J];養(yǎng)殖技術(shù)顧問(wèn);2008年03期
2 ;我國(guó)自主研發(fā)豬藍(lán)耳病疫苗告別進(jìn)口[J];吉林畜牧獸醫(yī);2011年03期
3 ;藍(lán)耳病疫苗使用時(shí)的注意事項(xiàng)[J];北方牧業(yè);2012年23期
4 ;豬藍(lán)耳病疫苗研制成功[J];臺(tái)灣農(nóng)業(yè)情況;1995年01期
5 ;天津研制成功豬藍(lán)耳病疫苗[J];北方牧業(yè);2004年19期
6 ;打藍(lán)耳病疫苗時(shí)的注意事項(xiàng)[J];北方牧業(yè);2006年24期
7 林太明;;警惕豬藍(lán)耳病疫苗使用不當(dāng)?shù)奈：J];養(yǎng)豬;2007年04期
8 花象柏;;豬藍(lán)耳病疫苗預(yù)防探討[J];獸藥與飼料添加劑;2008年03期
9 梁皓儀;;不同藍(lán)耳病疫苗的免疫效果—抗體效價(jià)分析[J];養(yǎng)豬;2008年04期
10 吳華偉;金麗霞;陳征;鄭明;;藍(lán)耳病疫苗的正確使用[J];中國(guó)獸藥雜志;2009年10期
相關(guān)會(huì)議論文 前4條
1 ;豬藍(lán)耳病疫苗的研究[A];新型疫苗研發(fā)及基因工程疫苗應(yīng)用研討會(huì)論文集[C];2010年
2 張長(zhǎng)龍;嚴(yán)寶英;賈文孝;劉學(xué)通;;豬瘟、豬口蹄疫、高致病性豬藍(lán)耳病疫苗有效免疫擴(kuò)大試驗(yàn)初探[A];中國(guó)畜牧獸醫(yī)學(xué)會(huì)家畜傳染病學(xué)分會(huì)第七屆全國(guó)會(huì)員代表大會(huì)暨第十三次學(xué)術(shù)研討會(huì)論文集（上冊(cè)）[C];2009年
3 陳建林;楊肖;王澤洲;章歡;程馳;李棟;王紅寧;李江凌;高榮;;豬白細(xì)胞介素4、6融合基因和CpG基序?qū)ωi藍(lán)耳病疫苗免疫的強(qiáng)化效應(yīng)[A];中國(guó)畜牧獸醫(yī)學(xué)會(huì)家畜傳染病學(xué)分會(huì)第七屆全國(guó)會(huì)員代表大會(huì)暨第十三次學(xué)術(shù)研討會(huì)論文集（上冊(cè)）[C];2009年
4 宋羚羚;杜春玲;余志;廖曉東;李巒峰;惠覓宙;;激流式生物反應(yīng)器培養(yǎng)Marc-145細(xì)胞生產(chǎn)豬藍(lán)耳病疫苗工藝研究[A];中國(guó)畜牧獸醫(yī)學(xué)會(huì)動(dòng)物傳染病學(xué)分會(huì)第四次豬病防控學(xué)術(shù)研討會(huì)論文集[C];2010年
相關(guān)重要報(bào)紙文章 前10條
1 肖柳;豬藍(lán)耳病疫苗“錢(qián)”景尚不明朗[N];證券時(shí)報(bào);2007年
2 胡軍華;豬藍(lán)耳病疫苗助力 中牧實(shí)業(yè)利潤(rùn)增近九成[N];第一財(cái)經(jīng)日?qǐng)?bào);2008年
3 朱兵;豬藍(lán)耳病疫苗[N];江蘇農(nóng)業(yè)科技報(bào);2003年
4 董少東;158萬(wàn)頭生豬免費(fèi)打藍(lán)耳病疫苗[N];北京日?qǐng)?bào);2007年
5 郭艾琳;12藥企緊急投產(chǎn)豬藍(lán)耳病疫苗 市場(chǎng)前景難定[N];第一財(cái)經(jīng)日?qǐng)?bào);2007年
6 吳桂亮;健康豬才能接種藍(lán)耳病疫苗[N];江蘇農(nóng)業(yè)科技報(bào);2007年
7 袁小可;首批豬藍(lán)耳病疫苗下線揭幕8億新市場(chǎng)[N];上海證券報(bào);2007年
8 郭立;全國(guó)首批豬藍(lán)耳病疫苗發(fā)放[N];西部時(shí)報(bào);2007年
9 ;藍(lán)耳病疫苗全國(guó)統(tǒng)一調(diào)撥停止[N];中國(guó)畜牧獸醫(yī)報(bào);2007年
10 趙海;天津研制出豬藍(lán)耳病疫苗[N];農(nóng)資導(dǎo)報(bào);2004年
相關(guān)碩士學(xué)位論文 前4條
1 郭士琪;豬瘟與豬藍(lán)耳病疫苗不同免疫程序?qū)γ庖咝Ч绊懙难芯縖D];沈陽(yáng)農(nóng)業(yè)大學(xué);2016年
2 王國(guó)強(qiáng);豬藍(lán)耳病疫苗免疫應(yīng)激及其免疫增強(qiáng)調(diào)節(jié)劑的研究[D];湖南農(nóng)業(yè)大學(xué);2009年
3 楊竹鳴;pVAX1-IFN-α作為豬藍(lán)耳病疫苗免疫佐劑的評(píng)價(jià)[D];南京農(nóng)業(yè)大學(xué);2012年
4 竇鵬勛;豬瘟、口蹄疫與藍(lán)耳病疫苗單獨(dú)和聯(lián)合免疫后豬體抗體水平的變化[D];西北農(nóng)林科技大學(xué);2009年
，本文編號(hào)：1396276
本文鏈接：http://www.sikaile.net/yixuelunwen/dongwuyixue/1396276.html
